Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Details about COVID-19, monkeypox, and the flu vaccine

CLINICAL TRIALS
About Clinical Trials Find a Clinical Trial
CLINICAL TRIALS
About Clinical Trials Find a Clinical Trial

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

Trial ID or NCT#

NCT01336803

Status

recruiting iconRECRUITING

Purpose

This pilot trial studies the differentiation of bone sarcomas and osteomyelitis with ferumoxytol-enhanced magnetic resonance imaging (MRI). Imaging procedures that allow doctors to more accurately differentiate between malignant bone sarcomas and osteomyelitis may help in diagnosing patients correctly and may result in more timely treatment.

Official Title

Pilot Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

Eligibility Criteria

Ages Eligible for Study: 10 Years to 21 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Heike Daldrup-Link
Heike Daldrup-Link
Pediatric radiologist
Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)
Neyssa Marina

Contact us to find out if this trial is right for you.

CONTACT

Anne Muehe
(650) 724-3191

SEND MESSAGE

View on ClinicalTrials.gov